Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Case Reports in Hematology|August 24, 2013
Nonfamilial, MPL S505N-Mutated Essential ThrombocythaemiaRuth Morrell, Stephen E Langabeer, Liam Smyth, et al.British Journal of Haematology|April 19, 2020
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjectsLiam Smyth, Danielle N Blunt, Evgenia Gatov, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2021
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based RegistryDanielle N Blunt, Liam Smyth, Chenthila Nagamuthu, et al.Multiple Sclerosis and Related Disorders|June 16, 2024
Neuropsychological outcomes following HSCT in MS: A systematic reviewLaura Davenport, Mathew McCauley, Erin Breheny, et al.Multiple Sclerosis and Related Disorders|November 16, 2024
A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple SclerosisLaura Davenport, Mathew McCauley, Liam Smyth, et al.Epilepsy Research and Treatment|September 7, 2012
A seizure care pathway in the emergency department: preliminary quality and safety improvementsParameswaran M Iyer, Patricia H McNamara, Margaret Fitzgerald, et al.Clinical Lymphoma, Myeloma & Leukemia|June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive DisorderLaura McDonald, Roseann O' Doherty, Eileen Ryan, et al.Leukemia & Lymphoma|September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLLNiamh Appleby, David O'Brien, Fiona M Quinn, et al.Pageof 1